NCT07797998Not yet recruiting
Association of Diet and IBD
Association of Nutritional Status, Dietary Inflammatory Index, and Hematological Inflammatory Biomarkers With Disease Activity in Patients With Inflammatory Bowel Disease.
Source: ClinicalTrials.gov · Last updated 1 Sept 2026
Brief summary (registry, in English)
The study investigate the nutritional status and inflammatory markers and diet inflammatory index in patients with IBD and their effect on disease activity.
- Status (registry)
- Not yet recruiting
- Study type
- Observational
- Enrollment
- 100 (estimated)
- First submitted
- 24 Aug 2026
- Start date
- Oct 2026
- Primary completion date
- Jan 2028
- Lead sponsor
- Assiut University
- Diseases
- Crohn's disease, Ulcerative colitis
- NCT number
- NCT07797998
What you commit to
- Study type: Observational
- Planned participants: 100
- From Oct 2026 to the primary completion date, Jan 2028
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Patients with previously identified thyroid illness.
- Patient with a previous history of bariatric surgery.
Other illness
- Patients with acute infection.
- Patients known to have a malignancy.
Other
- Patients with major surgeries or recent trauma within the last 6 months.
Who the study is looking for
- Patients aged 18-65 years.
- patients diagnosed with either Crohn's disease or ulcerative colititis
Age in the registry: 18 years to 65 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Assiut University Coordinator of this site? Confirm its status | Asyut | Egypt | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.